Case Report: Personalized peptide-based immunization in an advanced-stage prostate cancer patient with bone metastasis

Case Report: Personalized peptide-based immunization in an advanced-stage prostate cancer patient with bone metastasis

Neoantigens, which are recognized as non-self and trigger an immune response, are novel antigens generated by tumor cells. Here, we report a de novo metastatic hormone-sensitive prostate cancer (mHSPC) case, which benefited from our personalized peptide immunization named BioInformatic Tumor Address...

Full description

Saved in:
Bibliographic Details
Main Authors: Nils Heinrich Thoennissen, Mari Carmen Martos-Contreras, Mehdi Manoochehri, Mauro Nogueira, Franziska Bremm, Jan Dörrie, Jan Christoph, Meik Kunz, Wolfgang Schönharting
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
neoantigen
peptide
prostate cancer
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1596315/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1596315/full

Similar Items